acridines has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolger, GB; De Souza, PL; Fujimori, M; Khoo, KS; Lim, R; North, S; Phillips, J; Spiridonidis, H | 1 |
| Bersteĭn, LM; Konstantinova, MM; Surkov, KG; Tsyrlina, EV | 1 |
2 trial(s) available for acridines and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Castration; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Pyrazoles; Quality of Life; Survival Rate; Treatment Outcome | 2010 |
[Neovir, an interferon inductor, modifies expression of steroid hormone receptors in hormone-dependent tissues and restores sensitivity to tamoxifen in patients with inoperable breast cancer].
Topics: Acridines; Animals; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Interferon Inducers; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Tamoxifen | 1996 |